in Diabetes patient treated with argwadha kwatha virechan

Evaluation of the effect of Argwadha kwatha nitya virechana and Nishakathkadi kwatha in Madhumeha(Diabetes Mellitus II)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/07/026480

Enrollment

150

Registered

2020-07-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Argwadha kwatha: Argwadha Kwatha Nitya virechan 60 ml orally.one time morning. for 21 days Control Intervention1: Nishakathkadi kwatha: Nishakathakadi kwatha 20 ml orally.two time after

Eligibility

Inclusion criteria

Inclusion criteria: freshly diagnosed Diabetes ICD 10 criteria E11, uncomplicated NIDDM type 2, non ketoic, fit for Virechan

Exclusion criteria

Exclusion criteria: below 20-above 60.pregnancy, puperium period, glysoria or renal, imapired glucose tolaerance, DM type 1, on Insuline therepy.nephropathy, retinopathy.

Design outcomes

Primary

Measure	Time frame
Lowering of blood sugar level.Timepoint: After 3 weeks of administration of drug. It shows the lowering of blood sugar.	—

Secondary

Measure	Time frame
symptomatic relief in the Madhumeha.Timepoint: 21 dyas	—

Countries

India

Contacts

Public ContactDr Shilpa Bhaskarrao Deshpande

MGACH and RC, salod Wardha.

sbdeshpande107@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026